• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number UNK-CV-SR-VALIANT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Ischemia (1942); Pain (1994); Paralysis (1997); Renal Failure (2041); Numbness (2415); Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440); Swelling/ Edema (4577)
Event Date 04/05/2017
Event Type  Injury  
Event Description
Valiant stent grafts (22x100mm) was implanted during the emergent tevar treatment of a blunt thoracic aortic injury (btai) with transection distal to the left subclavian artery origin on an unknown date.The injury was noted as 40mm long beginning 10mm distal to the lsca.The aortic diameter was noted as 22mm just distal to the lca and 18mm in the mid descending aorta.It was reported approximately 9 months post the index procedure the patient presented with sudden painful paresthesia below the waist and swelling of the left foot and began experiencing chest pain 3 days after onset of symptoms.It was reported the patient collapsed and was transferred to hospital.Decreased motor function and sensation were noted in the bilateral lower extremities.Ct demonstrated near occlusive thrombosis within the distal portion of the thoracic stent.Heparin therapy was commenced.The patient developed renal failure and abdominal pain with lower gastrointestinal bleeding.No obvious structural defects of the endografts including stent collapse, migration or gross infolding were seen.A right axillofemoral bypass was performed for the lower extremity ischemia.Post op the patients biphasic pules returned in the bilateral extremities, neurological function returned to baseline and bowel and renal injury resolved after 3 days of hemodialysis.Per the physician the cause of the adverse events are undetermined.No additional clinical sequelae were reported and the patient will be monitored.
 
Manufacturer Narrative
Medtronic received the following information from a journal article entitled;safety and durability of single-stage type i hybrid total aortic arch repair for extensive aortic arch disease: symptomatic intragraft thrombus following endovascular repair of blunt thoracic aortic injury abdoli et al, annals of vascular surgery (42) 305.27-305.E12 https://doi.Org/10.1016/j.Avsg.2016.12.007.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13289201
MDR Text Key284014564
Report Number9612164-2022-00270
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-CV-SR-VALIANT
Device Catalogue NumberUNK-CV-SR-VALIANT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/17/2022
Initial Date FDA Received01/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age29 YR
-
-